MediXall Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MediXall Group generated cash of -$3,561,083, which is more than the previous year. Cash used in financing activities reached the amount of $3,502,460 last year. Net change in cash is therefore -$60,002.
Cash Flow
| 2013 | -318.07K | 0 | 363.55K |
|---|---|---|---|
| 2014 | -48.44K | 0 | 3.34K |
| 2015 | 24.62K | -25K | 45K |
| 2016 | -666.15K | 0 | 781.12K |
| 2017 | -2.06M | -179.30K | 2.32M |
| 2018 | -2.22M | -281.54K | 2.51M |
| 2019 | -2.34M | -15.74K | 2.60K |
| 2020 | -3.50M | -715.15K | 4.41M |
| 2021 | -4.68M | -12.84K | 4.11M |
| 2022 | -3.56M | -1.37K | 3.50M |
MDXL Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 63.41K | 645.76K | 446.21K | 201.50K | 191.44K | 114.97K | 0 | 378 | 45.47K | 0 |
Operating activities | ||||||||||
Net income | -6.83M | -6.20M | -5.93M | -3.42M | -2.98M | -1.64M | -657.16K | -348.62K | -684.08K | -988.19K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 35.71K | 4K | 4K | 69.94K | 3.14K | 3K | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 1.96M | 1.36K | 1.66M | 643.25K | 0 | 0 | 0 | 45 | 45K | 349.28K |
| Deferred income tax benefit | 1.96M | 1.36K | 1.66M | 643.25K | 0 | 0 | 0 | 45 | 45K | 349.28K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 623.58K | 160.59K | -138.79K | -21 | 0 | 0 | -100 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 595.16K | 17.46K | 410.62K | 26.95K | -196.59K | -428.22K | -8.99K | -37.16K | 338.55K | 67.98K |
Cash generated by operating activities | -3.56M | -4.68M | -3.50M | -2.34M | -2.22M | -2.06M | -666.15K | 24.62K | -48.44K | -318.07K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25K | 0 | 0 |
Investments In Property Plant And Equipment | -1.37K | -12.84K | -91.57K | -15.74K | -281.54K | -179.30K | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.37K | -12.84K | -715.15K | -15.74K | -281.54K | -179.30K | 0 | -25K | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 780.5K | 1.84M | 2.61M | 2.60M | 2.51M | 2.46M | 781.12K | 45K | 3.34K | 363.55K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 2.72M | 0 | -165.71K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 3.50M | 4.11M | 4.41M | 2.60K | 2.51M | 2.32M | 781.12K | 45K | 3.34K | 363.55K |
Net Change In Cash | -60.00K | -582.34K | 199.54K | 244.71K | 10.06K | 76.46K | 114.97K | -378 | -45.10K | 45.47K |
Cash at end of period | 3.41K | 63.41K | 645.76K | 446.21K | 201.50K | 191.44K | 114.97K | 0 | 378 | 45.47K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |